Thermo Fisher Scientific reports Q1 2026 earnings on April 23, projecting $5.25 EPS and $10.8606B revenue; yielded $6.57 EPS and $12.22B revenue. Consolidated Investment Group cut its stake 21.8%, holding 10,730 shares worth $6.217M, while Capital World Investors raised position 7.4%.
Comments